Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Renuka Jain

Cardiovascular Disease Milwaukee, WI Medical Doctor

NPI 1811037161 CMS profile 1212073

2801 W Kinnickinnic River Pkwy, Ste 130, Milwaukee, WI 53215

Open in the dashboard

General payments

$130,630

325 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$209,083 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Renuka Jain of Milwaukee, WI is reported in the CMS Open Payments database as having received $130,630 across 325 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $209,083 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,214 35
2024 General $35,789 96
2023 General $39,094 77
2022 General $18,899 55
2021 General $1,817 23
2020 General $6,030 19
2019 General $12,787 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Renuka Jain
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Renuka Jain were reported at $16,214. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Renuka Jain Cardiovascular Disease median Middle half National median
2019 $12,787 $450 $127–$1,392 $163
2020 $6,030 $242 $77–$751 $114
2021 $1,817 $335 $101–$1,037 $132
2022 $18,899 $395 $121–$1,211 $149
2023 $39,094 $443 $136–$1,283 $160
2024 $35,789 $450 $136–$1,323 $164
2025 $16,214 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $104,113 248 payments
  2. Medtronic Vascular, Inc. $16,106 15 payments
  3. Abbott Laboratories $3,133 26 payments
  4. Edwards Lifesciences Corporation $2,398 17 payments
  5. Ancora Heart, Inc. $2,209 6 payments
  6. Philips Electronics North America Corporation $1,954 2 payments
  7. Boston Scientific Corporation $279 4 payments
  8. Siemens Medical Solutions USA, Inc. $137 1 payment
  9. HeartFlow, Inc. $136 1 payment
  10. Ge Healthcare $112 2 payments
  11. Other $55 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $52,613 17 payments
  2. Travel and Lodging $38,417 148 payments
  3. Consulting Fee $24,422 5 payments
  4. Food and Beverage $9,954 152 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,000 1 payment
  6. Honoraria $1,925 1 payment
  7. Compensation for serving as faculty or as a speaker for a medical education program $1,300 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $63,444 94 payments
  2. CoreValve Evolut Transcatheter Valve Systems $13,850 11 payments
  3. AccuCinch $2,209 6 payments
  4. (1667) Ultrasound Options and Upgrades $1,925 1 payment
  5. Mitra Clip system $1,809 11 payments
  6. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $737 6 payments
  7. CoreValve Evolut Transcatheter Valve Systems $634 8 payments
  8. MitraClip System $460 7 payments
  9. Avalus $167 1 payment
  10. WATCHMAN Access System $157 2 payments
  11. Other $800 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$117,052

Of which drugs: $3,867

Medicare patients

1,482

Average age 75

Services billed

4,187

670 women, 812 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 66%
Heart failure 61%
Chronic kidney disease 55%
Arthritis 54%
Atrial fibrillation 50%
Diabetes 44%
COPD 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, perflutren lipid microspheres, per ml Q9957 Office 58 120 $3,867

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

325 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record